Hanover Insurance Group Reports Record Q4 2025 Earnings, Beats EPS Estimates, Misses Revenue Forecast

THG
February 04, 2026

The Hanover Insurance Group, Inc. (NYSE: THG) reported record fourth‑quarter 2025 results, posting net income of $198.5 million ($5.47 per diluted share) and operating income of $210.1 million ($5.79 per diluted share). Full‑year 2025 net income rose to $662.5 million ($18.16 per diluted share) and operating income reached $696.2 million ($19.09 per diluted share). Revenue for the quarter was $1.67 billion, slightly below the consensus estimate of $1.71 billion, while the combined ratio improved to 89.0 % for the quarter and 91.6 % for the year.

The earnings beat analysts’ expectations by $0.27 per share, a 5.2 % lift over the $5.20 consensus estimate. The outperformance was driven by disciplined pricing, a favorable mix shift toward higher‑margin personal lines, and lower loss ratios. Operating leverage and cost control also helped, as the company maintained underwriting profitability while expanding its geographic footprint.

Revenue fell 2.4 % from $1.71 billion to $1.67 billion, a miss of $40 million versus the $1.71 billion consensus. The shortfall was largely due to modest premium growth in the core commercial segment, offset by a 4.4 % increase in personal lines premiums. Specialty revenue grew at a slower pace because of intensified competition in that space, while net investment income rose 24.9 % to $1.12 billion, supporting the overall top‑line.

The combined ratio of 89.0 % for the quarter and 91.6 % for the year reflects a 3.4‑point improvement in the Personal Lines ex‑CAT ratio, which moved to 85.8 % from 89.2 % in the prior year. The improvement was driven by disciplined pricing, a shift toward higher‑margin products, and geographic diversification that reduced exposure to any single market. The company’s operating return on equity climbed to 23.1 % in the quarter and 20.1 % for the year, the highest in its history.

Management highlighted the results as evidence of disciplined execution. CEO John C. Roche said, “We delivered outstanding results in 2025, with a strong fourth quarter that capped a record year driven by disciplined execution across the company.” CFO Jeffrey M. Farber added, “We wrapped up the year on a high note with an excellent fourth‑quarter combined ratio of 89 % and operating return on equity of 23.1 %.” The company guided for mid‑single‑digit growth in net written premiums for 2026, a 27 % increase in book value to $100.90 per share, a dividend increase to $0.95 per share, and $55 million in share repurchases during the quarter.

Market reaction was muted. After the release, the stock rose 3.55 % in after‑hours trading but fell 1.33 % in pre‑market trading the next day. Investors weighed the strong EPS beat against the revenue miss and the company’s guidance, which signals confidence in profitability but a cautious outlook for growth amid competitive pressures in specialty lines and higher state income taxes.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.